Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Acne Vulgaris (Dermatology) - Drugs In Development, 2021
US$ 2,000.00
Acne Vulgaris (Dermatology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acne Vulgaris - Drugs In Development, 2021, provide...
July 2021
252 pages
Adenosine Receptor A3 - Drugs In Development, 2021
US$ 3,500.00
Adenosine Receptor A3 - Drugs In Development, 2021 SUMMARY Adenosine Receptor A3 (ADORA3) - The adenosine A3 receptor, also known as ADORA3, is an adenosine receptor. Adenosine A3 receptors are G prot...
July 2021
96 pages
Anal Cancer (Oncology) - Drugs In Development, 2021
US$ 2,000.00
Anal Cancer (Oncology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anal Cancer - Drugs In Development, 2021, provides an ov...
July 2021
813 pages
Blepharitis (Ophthalmology) - Drugs In Development, 2021
US$ 2,000.00
Blepharitis (Ophthalmology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Blepharitis - Drugs In Development, 2021, provides...
July 2021
79 pages
C-C Chemokine Receptor Type 4 - Drugs In Development, 2021
US$ 3,500.00
C-C Chemokine Receptor Type 4 - Drugs In Development, 2021 SUMMARY C-C Chemokine Receptor Type 4 (K5-5 or CD194 or CCR4) pipeline Target constitutes close to 9 molecules. Out of which approximately 8...
July 2021
63 pages
Cat Allergy (Immunology) - Drugs In Development, 2021
US$ 2,000.00
Cat Allergy (Immunology) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cat Allergy - Drugs In Development, 2021, provides an...
July 2021
35 pages
Chemotherapy Induced Anemia - Drugs In Development, 2021
US$ 2,000.00
Chemotherapy Induced Anemia - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Anemia - Drugs In Development,...
July 2021
77 pages
Cough (Respiratory) - Drugs In Development, 2021
US$ 2,000.00
Cough (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cough - Drugs In Development, 2021, provides an overview of...
July 2021
132 pages
Cystic Fibrosis (Respiratory) - Drugs In Development, 2021
US$ 2,500.00
Cystic Fibrosis (Respiratory) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Drugs In Development, 2021, pro...
July 2021
545 pages
Drug Overdose - Drugs In Development, 2021
US$ 2,000.00
Drug Overdose - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug Overdose - Drugs In Development, 2021, provides an overview...
July 2021
102 pages
